Clariant expands into controlled substances
Clariant's pharmaceutical fine chemicals business announced a series of upgrades to its manufacturing facilities around the world, headed by a new push into contract manufacture of controlled substances.
Archives for December 15, 2004
Miltenyi Biotec sets up Singapore HQ
Miltenyi Biotec strengthened its presence in the Asia-Pacific Rim by opening new headquarters in Suntec City, Singapore. The magnetic cell separation and cellular therapy specialists already have a presence in several European countries as well as the US.
EPO revokes Applera's PCR patent
Applera suffered a setback to its European sector after the European Patent Office revoked its patent covering real-time PCR thermal cycler technology.
Genevac launches EZ-Bio
Genevac has launched a brand new evaporation system aimed at the molecular biology market. The technology marks a significant departure for the company as its products have been focussed on drug discovery chemistry until now.
Merck slashes staff and revamps R&D
Merck & Co, still reeling from the impact of pulling its painkiller Vioxx (rofecoxib) from the market, is to slash its staff by 5,100 positions in a bid to save hundreds of millions of dollars by the end of the year.
European cell-based assay use to grow
Cell-based assays are set to become the preferred choice of screening, potentially overtaking more traditional approaches that include traditional enzyme- or antibody-based assays.
Making DNA without bacteria
CytoGenix has filed a patent application for a technology that it claims could dramatically increase the efficiency of DNA production.
New fine chemicals group formed in Europe
The European Chemical Industry Council (CEFIC) has set up a new umbrella group to represent the fine chemicals industry and provide forum to tackle the volatile environment facing the sector.
Artificial tongue helps medicine go down
Japan's Insent has developed an artificial tongue - said to be the first of its kind - that can be used to analyse the taste profiles of pharmaceuticals, foods and beverages.